Results 101 to 110 of about 115,388 (336)
Impact of Processing on Surface Structure of Human Cardiac Valve Allografts
Acta Medica, 2004 Methods of processing and cryopreservation are believed to be the most important factors of long term clinical performance of biological heart valve prostheses.
Otakar Krs +4 more
doaj +1 more source
Tissue Engineering. Part A, 2015 BACKGROUND Decellularized tissue-engineered heart valves (TEHVs) are under investigation as alternative for current heart valve prostheses with the potential to rapidly repopulate with cells within the body.
S. Ghazanfari +6 more
semanticscholar +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan +3 more
wiley +1 more source
Reoperações valvares: experiência do InCór-FMUSP Valvar reoperation
Brazilian Journal of Cardiovascular Surgery, 1991 Neste trabalho comparamos os resultados da mortalidade nas reoperações valvares, a fim de estabelecer a gravidade das reoperações conservadoras e das retrocas, analisando a influência do número de procedimentos nos resultados.
Pablo M. A Pomerantzeff +8 more
doaj
The immunogenicity of human cardiac valve allografts in vitro and in vivo [PDF]
, 1999 Allogeneic transplantation has become an accepted method for the replacement of diseased organs and tissues. The concept of cardiac valve transplantation for the replacement of semilunar valves was introduced by Lam et al in 1952'.
Hoekstra, F.M.E. (Franciska)
core +1 more source
Aortic valve replacement in patients aged 50 to 70 years: Improved outcome with mechanical versus biologic prostheses [PDF]
, 2008 ObjectiveImproved durability of bioprostheses has led some surgeons to recommend biologic rather than mechanical prostheses for patients younger than 65 years.
Brown, Morgan L. +7 more
core +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Aims Valve degeneration after DirectFlow implantation poses a challenge for valve‐in‐valve procedures due to its fragile polymeric structure and embolization risk. This study analyzes long‐term follow‐up of patients who underwent TAVI with DF to understand valve degeneration tendencies.
Dan M. Prunea +11 more
wiley +1 more source
Brazilian Journal of Cardiovascular Surgery, 1993 Apresentamos um instrumento cirúrgico inédito, o Suporte ADL, para cirurgia de substituição valvar cardíaca em qualquer das posições: aórtica, mitral ou tricúspide, por próteses biológicas ou mecânicas.
Arnaldo Duarte Lourenço
doaj
Biocompatibility Issue Of Tissue Engineered Heart Valves
Archives of Metallurgy and Materials, 2015 Tissue engineering is a new field of knowledge which creates the possibilities for producing bioactive cardiac prostheses that will characterize by biomechanical and morphological properties similar to native tissue.
Wilczek P.
doaj +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli +17 more
wiley +1 more source